Eritrodisestesia palmoplantar: prevención con frío local

• Autores: María Paz Serrano Fernández, María Jesús Gutiérrez Vilella, Ángeles Pérez Martín-Palanco, Francisco Vanaclocha Sebastián, Luis Cabezón Gutiérrez
• Localización: Revista ROL de enfermería, ISSN 0210-5020, Vol. 34, Nº. 9, 2011 (Ejemplar dedicado a: Nutrición enteral y complicaciones infecciosas. Especial Formación continuada 2011-2012), págs. 42-46
• Idioma: español
• Texto completo no disponible (Saber más ...)
• Referencias bibliográficas
  • Nagore E, Insa A, Sanmartin O. Antineoplastic therapy-induced palmar plantarerythrodysesthesia (‘hand-foot’) syndrome: incidence, recognition...
  • Lokich JJ, Moore C. Chemotherapy-associated palmar-plantar erythrodysest-hesia syndrome. Ann Intern Med 1984; 101: 798-799.
  • Comandone A, Bretti S, La Grotta G, et al. Palmar-plantar erythrodysesthesiasyndrome associated with 5-fluorouracil treatment. Anticancer...
  • Ellis GK, Livingstone RB, Gralow JR, et al. Dose-dense anthracycline-basedchemotherapy for node-positive breast cancer. J Clin Oncol 2002;...
  • Caeylx (pegylated liposomal doxorubicin). Product information, Schering-Plough Corporation; 2006.
  • Jacobi U, Waibler E, Schulze P, et al. Release of doxorubicin in sweat: first stepto induce the palmar-plantar erythrodysesthesia syndrome?...
  • Zuehlke KL. Erythematous eruption of palms and roles associated with mitota-ne therapy. Dermatologica 1974; 148: 90–92.
  • Bhasin S, Sunita, Gupta DK et al. Chemotherapy-induced palmer plantererythrodysesthesia. J Assoc Physicians India 2005; 53: 155–156.
  • Lin E, Morris JS, Ayers GD. Effect of celecoxib on capecitabine-indiced hand-foot syndrome and antitumor activity. Oncology (Williston Park)...
  • Abeloff MD, Armitage JO, Niederhuber JE, et al. Clinical oncology. 3rd ed.Philadelphia (PA): Churchill Livingstone; 2004.
  • Baack BR, Burgdorf WH. Chemotherapy-induced acral erythema. J Am AcadDermatol 1991;24:457–61.
  • Lyass O, Uziely B, Ben-Yosef R, et al. Correlation of toxicity with pharmacoki-netics of pegylated liposomal doxorubicin (Doxil) in metastatic...
  • Gressett SM, Stanford BL, Hardwicke F. Management of hand-foot syndromeinduced by capecitabine. J Oncol Pharm Pract 2006;12:131-41.
  • Esteve E, Schillio Y, Vaillant L, Bensaid P, Missonnier F,Metman EH. Efficacitéde la corticothérapie séquentielle dans un cas d’érythème acral...
  • Komamura H, Higashiyama M, Hashimoto K, Takeda K, Kimura H, Tani Y.Three cases of chemotherapy-induced acral erythema. J Dermatol1995;22:116-21.
  • Titgan MA. Prevention of palmar-plantar erythrodysesthesia associated withliposome-encapsulated doxorubicin (Doxil) by oral dexamethasone....
  • Vukelja SJ, Lombardo FA, James WD, Weiss RB. Pyridoxine for the palmar-plantar erythrodysesthesia syndrome. Ann Intern Med 1989;111:688-9.
  • Nagore E, Sánchez-Motilla JM, Insa A, Febrer MI. Síndrome de eritrodiseste-sia palmo-plantar por 5-fluorouracilo: respuesta favorable al tratamiento...
  • López AM, Wallace L, Dorr RT, Koff M, Hersh EM, Alberts DS. Topical DMSOtreatment for pegylated liposomal doxorubicin-induced palmar-plantar...
  • Kara IO, Sahin B, Erkisi M. Palmar-plantar erythrodysesthesia due to doceta-xel-capecitabine therapy is treated with vitamin E without dose...
  • Baack BR, Burgdorf WH. Chemotherapy-induced acral erythema. J Am AcadDermatol 1991;24:457-61.
  • Susser WS, Whitaker-Worth DL, Grant-Kels JM. Mucocutaneous reactions tochemotherapy. J Am Acad Dermatol 1999;40:367-98.
  • Zimmerman GC, Keeling JH, Lowry M, Medina J, Von Hoff DD, Burris HA.Prevention of docetaxel-induced erythrodysesthesia with local hypothermia....
  • Molpus KL, Anderson LB, Craig CL, Puleo JG. The effect of regional coolingon toxicity associated with intravenous infusion of pegylated liposomal...
  • Mangili G, Petrone M, Gentile C, et al. Prevention strategies in palmar–plan-tar erythrodysesthesia onset:The role of regional cooling. GynecologicOncology...